Article Detail - JE Part A
MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
Date Posted: June 25, 2026
The following MolDX Local Coverage Determinations (LCDs) have completed the Open Public Meeting comment period and are now finalized under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
| Medicare Coverage Database Number | MolDX LCD Title |
|---|---|
| L40197 | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
| Medicare Coverage Database Number | MolDX Billing and Coding Article Title |
|---|---|
| A60217 | Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
| Medicare Coverage Database Number | Response to Comments |
|---|---|
| A60450 | Response to Comments: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
Effective Date: August 10, 2026
View Active MolDX LCDs on our website or the CMS MCD.